MicroRNA-224 is up-regulated in hepatocellular carcinoma through epigenetic mechanisms

FASEB Journal

Volumn 26, Issue 7, 2012, Pages 3032-3041

  Wang, Yu ^a,b   Toh, Han Chong ^b   Chow, Pierce ^d,f   Chung, Alexander Y F ^f   Meyers, David J ^e   Cole, Philip A ^e   Ooi, London L P J ^c,f   Lee, Caroline G L ^a,b,d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b Humphrey Oei Institute of Cancer Research   (Singapore)

^c DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^d DUKE NUS MEDICAL SCHOOL   (Singapore)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

EP300; HDAC; Histone acetylation; miR 224

Indexed keywords

ACYLTRANSFERASE INHIBITOR; E1A ASSOCIATED P300 PROTEIN; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 3; HISTONE DEACETYLASE INHIBITOR; HISTONE H3; MICRORNA; MICRORNA 224; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER TISSUE; CELL IMMORTALIZATION; CHROMOSOME XQ; CONTROLLED STUDY; EPIGENETICS; GENE EXPRESSION; GENE LOCUS; GENE OVEREXPRESSION; HISTONE ACETYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR; UPREGULATION;

ACETYLATION; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CHROMOSOMES, HUMAN, X; DNA PRIMERS; E1A-ASSOCIATED P300 PROTEIN; EPIGENESIS, GENETIC; HEP G2 CELLS; HISTONE DEACETYLASE 1; HISTONE DEACETYLASES; HISTONES; HUMANS; LIVER NEOPLASMS; MICRORNAS; RNA, NEOPLASM; RNA, SMALL INTERFERING; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84863191653     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.11-201855     Document Type: Article

References (32)

1. Boyle, P., and Levin, B. (2008) World Cancer Report 2008, International Agency for Research on Cancer, Lyon, France
2. Parkin, D. M., Bray, F., Ferlay, J., and Pisani, P. (2005) Global cancer statistics, 2002. CA Cancer J. Clin. 55, 74-108 (Pubitemid 40372904)
3. Wang, Y., and Lee, C. G. (2009) MicroRNA and cancer - focus on apoptosis. J. Cell. Mol. Med. 13, 12-23
4. Murakami, Y., Yasuda, T., Saigo, K., Urashima, T., Toyoda, H., Okanoue, T., and Shimotohno, K. (2006) Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 25, 2537-2545
5. Gramantieri, L., Ferracin, M., Fornari, F., Veronese, A., Sabbioni, S., Liu, C. G., Calin, G. A., Giovannini, C., Ferrazzi, E., Grazi, G. L., Croce, C. M., Bolondi, L., and Negrini, M. (2007) Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res. 67, 6092-6099 (Pubitemid 47037488)
6. Meng, F., Henson, R., Wehbe-Janek, H., Ghoshal, K., Jacob, S. T., and Patel, T. (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133, 647-658 (Pubitemid 47187346)
7. Huang, Y. S., Dai, Y., Yu, X. F., Bao, S. Y., Yin, Y. B., Tang, M., and Hu, C. X. (2008) Microarray analysis of microRNA expression in hepatocellular carcinoma and non-tumorous tissues without viral hepatitis. J. Gastroenterol. Hepatol. 23, 87-94 (Pubitemid 350265207)
8. Wang, Y., Lee, A. T., Ma, J. Z., Wang, J., Ren, J., Yang, Y., Tantoso, E., Li, K. B., Ooi, L. L., Tan, P., and Lee, C. G. (2008) Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 upregulation and apoptosis inhibitor-5 as a microRNA-224-specific target. J. Biol. Chem. 283, 13205-13215
9. Jiang, J., Gusev, Y., Aderca, I., Mettler, T. A., Nagorney, D. M., Brackett, D. J., Roberts, L. R., and Schmittgen, T. D. (2008) Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin. Cancer Res. 14, 419-427 (Pubitemid 351226109)
10. Varnholt, H., Drebber, U., Schulze, F., Wedemeyer, I., Schirmacher, P., Dienes, H. P., and Odenthal, M. (2008) MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology 47, 1223-1232 (Pubitemid 351547908)
11. Ladeiro, Y., Couchy, G., Balabaud, C., Bioulac-Sage, P., Pelletier, L., Rebouissou, S., and Zucman-Rossi, J. (2008) MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 47, 1955-1963 (Pubitemid 351952843)
12. Connolly, E., Melegari, M., Landgraf, P., Tchaikovskaya, T., Tennant, B. C., Slagle, B. L., Rogler, L. E., Zavolan, M., Tuschl, T., and Rogler, C. E. (2008) Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. Am. J. Pathol. 173, 856-864
13. Su, H., Yang, J. R., Xu, T., Huang, J., Xu, L., Yuan, Y., and Zhuang, S. M. (2009) MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res. 69, 1135-1142
14. Huang, X. H., Wang, Q., Chen, J. S., Fu, X. H., Chen, X. L., Chen, L. Z., Li, W., Bi, J., Zhang, L. J., Fu, Q., Zeng, W. T., Cao, L. Q., Tan, H. X., and Su, Q. (2009) Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. Hepatol. Res. 39, 786-794
15. Ura, S., Honda, M., Yamashita, T., Ueda, T., Takatori, H., Nishino, R., Sunakozaka, H., Sakai, Y., Horimoto, K., and Kaneko, S. (2009) Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology 49, 1098-1112
16. Pineau, P., Volinia, S., McJunkin, K., Marchio, A., Battiston, C., Terris, B., Mazzaferro, V., Lowe, S. W., Croce, C. M., and Dejean, A. (2010) miR-221 overexpression contributes to liver tumorigenesis. Proc. Natl. Acad. Sci. U. S. A. 107, 264-269
17. Wong, Q. W., Ching, A. K., Chan, A. W., Choy, K. W., To, K. F., Lai, P. B., and Wong, N. (2010) MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling. Clin. Cancer Res. 16, 867-875
18. Coulouarn, C., Factor, V. M., Andersen, J. B., Durkin, M. E., and Thorgeirsson, S. S. (2009) Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene 28, 3526-3536
19. Wang, Y., Lu, Y., Toh, S. T., Sung, W. K., Tan, P., Chow, P., Chung, A. Y., Jooi, L. L., and Lee, C. G. (2010) Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3. J. Hepatol. 53, 57-66
20. Selcuklu, S. D., Donoghue, M. T., and Spillane, C. (2009) miR-21 as a key regulator of oncogenic processes. Biochem. Soc. Trans. 37, 918-925
21. Wang, Y., and Lee, C. G. (2011) Role of miR-224 in hepatocellular carcinoma: a tool for possible therapeutic intervention? Epigenomics 3, 235-243
22. Li, Q., Wang, G., Shan, J. L., Yang, Z. X., Wang, H. Z., Feng, J., Zhen, J. J., Chen, C., Zhang, Z. M., Xu, W., Luo, X. Z., and Wang, D. (2010) MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion. J. Gastroenterol. Hepatol. 25, 164-171
23. Yao, G., Yin, M., Lian, J., Tian, H., Liu, L., Li, X., and Sun, F. (2010) MicroRNA-224 is involved in transforming growth factor-beta-mediated mouse granulosa cell proliferation and granulosa cell function by targeting Smad4. Mol. Endocrinol. 24, 540-551
24. Li, X., Shen, Y., Ichikawa, H., Antes, T., and Goldberg, G. S. (2009) Regulation of miRNA expression by Src and contact normalization: effects on nonanchored cell growth and migration. Oncogene 28, 4272-4283
25. Bowers, E. M., Yan, G., Mukherjee, C., Orry, A., Wang, L., Holbert, M. A., Crump, N. T., Hazzalin, C. A., Liszczak, G., Yuan, H., Larocca, C., Saldanha, S. A., Abagyan, R., Sun, Y., Meyers, D. J., Marmorstein, R., Mahadevan, L. C., Alani, R. M., and Cole, P. A. (2010) Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor. Chem. Biol. 17, 471-482
26. Kratz, A., Arner, E., Saito, R., Kubosaki, A., Kawai, J., Suzuki, H., Carninci, P., Arakawa, T., Tomita, M., Hayashizaki, Y., and Daub, C. O. (2010) Core promoter structure and genomic context reflect histone 3 lysine 9 acetylation patterns. BMC Genomics 11, 257
27. Johnsson, A., Durand-Dubief, M., Xue-Franzen, Y., Ronnerblad, M., Ekwall, K., and Wright, A. (2009) HAT-HDAC interplay modulates global histone H3K14 acetylation in gene-coding regions during stress. EMBO Rep. 10, 1009-1014
28. Dokmanovic, M., Clarke, C., and Marks, P. A. (2007) Histone deacetylase inhibitors: overview and perspectives. Mol. Cancer Res. 5, 981-989 (Pubitemid 350080267)
29. Fu, X. Y., Wang, H. Y., Tan, L., Liu, S. Q., Cao, H. F., and Wu, M. C. (2002) Overexpression of p28/gankyrin in human hepatocellular carcinoma and its clinical significance. World J. Gastroenterol. 8, 638-643 (Pubitemid 34918655)
30. Gui, J., Tian, Y., Wen, X., Zhang, W., Zhang, P., Gao, J., Run, W., Tian, L., Jia, X., and Gao, Y. (2010) Serum microRNA characterization identifies miR-885-5 p as a potential marker for detecting liver pathologies. Clin. Sci. (Lond.) 120, 183-193
31. Li, M., Luo, R. Z., Chen, J. W., Cao, Y., Lu, J. B., He, J. H., Wu, Q. L., and Cai, M. Y. (2011) High expression of transcriptional coactivator p300 correlates with aggressive features and poor prognosis of hepatocellular carcinoma. J. Transl. Med. 9, 5
32. Baylin, S. B., and Ohm, J. E. (2006) Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat. Rev. Cancer 6, 107-116 (Pubitemid 43361543)